1Mehta RL,Pascual MT,Soroko S,et al.Spectrum of acute renal failure in the intensive care unit.The PICARD experience.Kidney Int,2004,66:1613-1621.
2Mehta RL.Anticoagulation strategies for continuous renal replacement therapies:What works? Am J Kidney Dis,199628:8-4.
3Ronco C,Bellomo R,Homel P,et al.Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure:A prospective randomised trial.Lancet,2000,356:26-20.
4Bouman CS,Oudemans Van Straaten HM,Tijssen JG,et al.Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure:A prospective,randomized trial.Crit Care Med,2002,30:2205-2211.
5Mehta RL,McDonald B,Gabbai FB,et al.A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure.Kidney Int,2001,60:1154-1163.
6Uchino S,Fealy N,Baldwin I,et al.Continuous is not continuous:The incidence and impact of circuit "down time" on uraemic control during continuous veno-venous haemofiltration.Intensive Care Med,2003 29:575-578.
8Davenport A:The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit.Am J KidneyDis,1997,30:20-27.
9Kappelmayer J,Bernabei A,Edmunds LH Jr,et al.Tissue factor is expressed on monocytes during simulated extracorporeal circulation.Circ Res,1993,72:1075-1081.
10H.M.Oudemans van Straaten,J.P.J.Wester,A.C.J.M.de Pont,et al.Anticoagulation strategies in continuous renal replacement therapy:Can the choice be evidence based,Intensive Care Med,2006,32:188-102.
